Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ortiz Ruiz MJ"'
Autor:
Bhagwat SV; Eli Lilly and Company, Indianapolis, Indiana, United States., Mur C; Eli Lilly and Company, Madrid, Spain., Vandekopple M; Eli Lilly and Company, Indianapolis, IN, United States., Zhao B; Eli Lilly and Company, Indianapolis, IN, United States., Shen W; Eli Lilly and Company, Indianapolis, Indiana, United States., Marugán C; Eli Lilly (Spain), Alcobendas, Madrid, Spain., Capen A; Eli Lilly and Company, Indianapolis, IN, United States., Kindler L; Eli Lilly and Company, Indianapolis, IN, United States., Stephens JR; Eli Lilly and Company, Indianapolis, Indiana, United States., Huber L; Eli Lilly and Company, Indianapolis, IN, United States., Castanares MA; Eli Lilly and Company, Indianapolis, IN, United States., Garcia-Tapia D; Eli Lilly and Company, Indianapolis, IN, United States., Cohen JD; Eli Lilly and Company, Indianapolis, IN, United States., Bastian J; Eli Lilly and Company, Indianapolis, IN, United States., Mattioni B; Eli Lilly and Company, Indianapolis, IN, United States., Yuen E; Eli Lilly and Company, United States., Baker TK; Eli Lilly and Company, United States., Rodriguez Cruz V; Eli Lilly and Company, United States., Fei D; Eli Lilly and Company, United States., Manro JR; Eli Lilly and Company, Indianapolis, IN, United States., Pulliam N; Eli Lilly and Company, Indianapolis, IN, United States., Dowless MS; Eli Lilly and Company, Indianapolis, Indiana, United States., Ortiz Ruiz MJ; Eli Lilly and Company, Madrid, Spain., Yu C; Lilly (China), Shanghai, Shanghai, China., Puca L; Eli Lilly (United States), New York, New York, United States., Klippel A; Eli Lilly and Company, New York City, New York, United States., Bacchion F; Eli Lilly and Company, Indianapolis, IN, United States., Ismail-Khan R; Eli Lilly and Company, Indianapolis, IN, United States., Rodrik-Outmezguine V; Eli Lilly and Company, Indianapolis, IN, United States., Peng SB; Eli Lilly and Company, Indianapolis, IN, United States., Lallena MJ; Eli Lilly and Company, Madrid, Spain., Gong X; Eli Lilly and Company, Indianapolis, Indiana, United States., de Dios A; Eli Lilly (United States), Indianapolis, United States.
Publikováno v:
Cancer research [Cancer Res] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.
Autor:
Guillén-Pérez YM; Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC)-Consejo Superior de Investigaciones Científicas (CSIC), 37007 Salamanca, Spain., Ortiz-Ruiz MJ; Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC)-Consejo Superior de Investigaciones Científicas (CSIC), 37007 Salamanca, Spain., Márquez J; Canceromics Laboratory, Departamento de Biología Molecular y Bioquímica, Universidad de Málaga, 29010 Málaga, Spain.; Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND), Universidad de Málaga, 29010 Málaga, Spain., Pandiella A; Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC)-Consejo Superior de Investigaciones Científicas (CSIC), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 37007 Salamanca, Spain., Esparís-Ogando A; Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC)-Consejo Superior de Investigaciones Científicas (CSIC), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 37007 Salamanca, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Autor:
Friese-Hamim M; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Ortiz Ruiz MJ; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Bogatyrova O; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Keil M; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Rohdich F; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Blume B; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Leuthner B; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Czauderna F; Research Unit Oncology, EMD Serono Research & Development Institute Inc., Billerica, Massachusetts., Hahn D; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Jabs J; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Jaehrling F; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Heinrich T; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Kellner R; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Chan K; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada., Tong AHY; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada., Wienke D; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Moffat J; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.; Institute for Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada., Blaukat A; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Zenke FT; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Feb 01; Vol. 23 (2), pp. 159-173.
Autor:
Calpena E; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK., Hervieu A; Cancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK., Kaserer T; Cancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK., Swagemakers SMA; Department of Pathology and Department of Bioinformatics, Erasmus University Medical Center, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands., Goos JAC; Department of Plastic and Reconstructive Surgery, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands., Popoola O; Cancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK., Ortiz-Ruiz MJ; Cancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK., Barbaro-Dieber T; Genetics Division, Cook Children's Medical Center, Fort Worth, TX 76102, USA., Bownass L; Department of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, St. Michael's Hospital, Bristol BS2 8EG, UK., Brilstra EH; Department of Genetics, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, the Netherlands., Brimble E; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA., Foulds N; Wessex Clinical Genetics Services, University Hospital Southampton, Southampton SO16 5YA, UK., Grebe TA; Department of Child Health, University of Arizona College of Medicine, Division of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ 85016, USA., Harder AVE; Department of Genetics, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, the Netherlands., Lees MM; North Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3EH, UK., Monaghan KG; GeneDx, Gaithersburg, MD 20877, USA., Newbury-Ecob RA; Department of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, St. Michael's Hospital, Bristol BS2 8EG, UK., Ong KR; Department of Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK., Osio D; Department of Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK., Reynoso Santos FJ; Genetics Division, Joe DiMaggio Children's Hospital, Hollywood, FL 33021, USA; Charles E. Schmidt College of Medicine, Florida Atlantic University, Hollywood, FL 33021, USA., Ruzhnikov MRZ; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA., Telegrafi A; GeneDx, Gaithersburg, MD 20877, USA., van Binsbergen E; Department of Genetics, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, the Netherlands., van Dooren MF; Department of Clinical Genetics, Erasmus MC University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands., van der Spek PJ; Department of Pathology and Department of Bioinformatics, Erasmus University Medical Center, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands., Blagg J; Cancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK., Twigg SRF; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK., Mathijssen IMJ; Department of Plastic and Reconstructive Surgery, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands., Clarke PA; Cancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK. Electronic address: paul.clarke@icr.ac.uk., Wilkie AOM; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK. Electronic address: andrew.wilkie@imm.ox.ac.uk.
Publikováno v:
American journal of human genetics [Am J Hum Genet] 2019 Apr 04; Vol. 104 (4), pp. 709-720. Date of Electronic Publication: 2019 Mar 21.
Autor:
Sánchez-Fdez A; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; IBSAL, Salamanca, Spain.; CIBERONC, Salamanca, Spain., Ortiz-Ruiz MJ; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; IBSAL, Salamanca, Spain., Re-Louhau MF; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; IBSAL, Salamanca, Spain., Ramos I; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain., Blanco-Múñez Ó; IBSAL, Salamanca, Spain.; Pathology Service, University Hospital, Salamanca, Spain., Ludeña D; IBSAL, Salamanca, Spain.; Pathology Service, University Hospital, Salamanca, Spain., Abad M; IBSAL, Salamanca, Spain.; Pathology Service, University Hospital, Salamanca, Spain., Sánchez-Martín M; CIBERONC, Salamanca, Spain.; Transgenic Facility of the Nucleus Platform, University of Salamanca, Salamanca, Spain., Pandiella A; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; IBSAL, Salamanca, Spain.; CIBERONC, Salamanca, Spain., Esparís-Ogando A; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; IBSAL, Salamanca, Spain.; CIBERONC, Salamanca, Spain.
Publikováno v:
The European respiratory journal [Eur Respir J] 2019 Feb 28; Vol. 53 (2). Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).
Autor:
Clarke PA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Ortiz-Ruiz MJ; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., TePoele R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Adeniji-Popoola O; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Box G; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Court W; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Czasch S; Merck KGaA, Darmstadt, Germany., El Bawab S; Merck KGaA, Darmstadt, Germany., Esdar C; Merck KGaA, Darmstadt, Germany., Ewan K; School of Bioscience, Cardiff University, Cardiff, United Kingdom., Gowan S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., De Haven Brandon A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Hewitt P; Merck KGaA, Darmstadt, Germany., Hobbs SM; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Kaufmann W; Merck KGaA, Darmstadt, Germany., Mallinger A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Raynaud F; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Roe T; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Rohdich F; Merck KGaA, Darmstadt, Germany., Schiemann K; Merck KGaA, Darmstadt, Germany., Simon S; Merck KGaA, Darmstadt, Germany., Schneider R; Merck KGaA, Darmstadt, Germany., Valenti M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Weigt S; Merck KGaA, Darmstadt, Germany., Blagg J; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Blaukat A; Merck KGaA, Darmstadt, Germany., Dale TC; School of Bioscience, Cardiff University, Cardiff, United Kingdom., Eccles SA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Hecht S; Merck KGaA, Darmstadt, Germany., Urbahns K; Merck KGaA, Darmstadt, Germany., Workman P; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Wienke D; Merck KGaA, Darmstadt, Germany.
Publikováno v:
ELife [Elife] 2016 Dec 09; Vol. 5. Date of Electronic Publication: 2016 Dec 09.
Autor:
Czodrowski P; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Mallinger A; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research , London, SW7 3RP, U.K., Wienke D; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Esdar C; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Pöschke O; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Busch M; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Rohdich F; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Eccles SA; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research , London, SW7 3RP, U.K., Ortiz-Ruiz MJ; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research , London, SW7 3RP, U.K., Schneider R; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Raynaud FI; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research , London, SW7 3RP, U.K., Clarke PA; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research , London, SW7 3RP, U.K., Musil D; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Schwarz D; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Dale T; School of Bioscience, Cardiff University , Cardiff, CF10 3AX, U.K., Urbahns K; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany., Blagg J; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research , London, SW7 3RP, U.K., Schiemann K; Merck KGaA , Frankfurter Strasse 250, Darmstadt, 64293, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2016 Oct 27; Vol. 59 (20), pp. 9337-9349. Date of Electronic Publication: 2016 Oct 07.
Autor:
Mallinger A; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Schiemann K; Merck KGaA , Darmstadt, 64293, Germany., Rink C; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Stieber F; Merck KGaA , Darmstadt, 64293, Germany., Calderini M; Merck KGaA , Darmstadt, 64293, Germany., Crumpler S; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Stubbs M; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Adeniji-Popoola O; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Poeschke O; Merck KGaA , Darmstadt, 64293, Germany., Busch M; Merck KGaA , Darmstadt, 64293, Germany., Czodrowski P; Merck KGaA , Darmstadt, 64293, Germany., Musil D; Merck KGaA , Darmstadt, 64293, Germany., Schwarz D; Merck KGaA , Darmstadt, 64293, Germany., Ortiz-Ruiz MJ; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Schneider R; Merck KGaA , Darmstadt, 64293, Germany., Thai C; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Valenti M; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., de Haven Brandon A; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Burke R; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Workman P; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Dale T; School of Bioscience, Cardiff University , Cardiff, CF10 3AX, U.K., Wienke D; Merck KGaA , Darmstadt, 64293, Germany., Clarke PA; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Esdar C; Merck KGaA , Darmstadt, 64293, Germany., Raynaud FI; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Eccles SA; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K., Rohdich F; Merck KGaA , Darmstadt, 64293, Germany., Blagg J; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, SW7 3RP, U.K.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2016 Feb 11; Vol. 59 (3), pp. 1078-101. Date of Electronic Publication: 2016 Jan 21.
Autor:
Dale T; School of Bioscience, Cardiff University, Cardiff, UK., Clarke PA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Esdar C; Merck KGaA, Merck Serono, Darmstadt, Germany., Waalboer D; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Adeniji-Popoola O; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Ortiz-Ruiz MJ; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Mallinger A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Samant RS; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Czodrowski P; Merck KGaA, Merck Serono, Darmstadt, Germany., Musil D; Merck KGaA, Merck Serono, Darmstadt, Germany., Schwarz D; Merck KGaA, Merck Serono, Darmstadt, Germany., Schneider K; Merck KGaA, Merck Serono, Darmstadt, Germany., Stubbs M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Ewan K; School of Bioscience, Cardiff University, Cardiff, UK., Fraser E; School of Bioscience, Cardiff University, Cardiff, UK., TePoele R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Court W; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Box G; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Valenti M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., de Haven Brandon A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Gowan S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Rohdich F; Merck KGaA, Merck Serono, Darmstadt, Germany., Raynaud F; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Schneider R; Merck KGaA, Merck Serono, Darmstadt, Germany., Poeschke O; Merck KGaA, Merck Serono, Darmstadt, Germany., Blaukat A; Merck KGaA, Merck Serono, Darmstadt, Germany., Workman P; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Schiemann K; Merck KGaA, Merck Serono, Darmstadt, Germany., Eccles SA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP., Wienke D; Merck KGaA, Merck Serono, Darmstadt, Germany., Blagg J; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2015 Dec; Vol. 11 (12), pp. 973-980. Date of Electronic Publication: 2015 Oct 26.
Autor:
Mallinger A; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SW7 3RP, U.K., Crumpler S, Pichowicz M, Waalboer D, Stubbs M, Adeniji-Popoola O, Wood B, Smith E, Thai C, Henley AT, Georgi K, Court W, Hobbs S, Box G, Ortiz-Ruiz MJ, Valenti M, De Haven Brandon A, TePoele R, Leuthner B, Workman P, Aherne W, Poeschke O, Dale T, Wienke D, Esdar C, Rohdich F, Raynaud F, Clarke PA, Eccles SA, Stieber F, Schiemann K, Blagg J
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2015 Feb 26; Vol. 58 (4), pp. 1717-35. Date of Electronic Publication: 2015 Feb 13.